Bloomberg News

Israeli Stocks: Teva, Ampal, Elad, Marathon, Gazit-Globe, Tower

January 23, 2012

Jan. 22 (Bloomberg) -- Israel’s TA-25 Index declined from an almost three-month high, slipping less than 0.1 percent to 1,136.43, at the 4:30 p.m. close in Tel Aviv.

The following stocks rose or fell today. Symbols are in parentheses.

Ampal-American Israel Corp. (AMPL IT), the owner of a stake in a company that exports gas from Egypt to Israel, advanced for the fifth time in six days, gaining 1.3 percent to 1.625 shekels. Ampal said the gas supply from Egypt to Israel has been restored partially after being halted following explosions on the Sinai-pipeline network.

Elad Canada Inc. (ELCN IT) gained to the highest level since Aug. 4, advancing 3.1 percent to 10.62 shekels. The real estate company said it plans to pay a dividend of 75 million shekels ($20 million).

Gazit-Globe Ltd. (GLOB IT) rose to the highest since Dec. 26, adding 1.1 percent to 37.38 shekels. The real-estate company agreed to sell about 134.7 million shekels of bonds and 1.3 million options to institutional investors.

Separately, the company said it bought 1 million shares of Atrium European Real Estate Ltd. (ATRS AV) for 3.58 euros each, increasing its stake in the manager of retail-real estate to 32.46 percent.

Marathon Investments Ltd. (MARA IT) soared 46 percent, the most since at least February 1996 when Bloomberg started tracking the stock, to 1.078 shekels. The venture capital fund said it is in talks to sell a unit for 210 million shekels.

Strauss Group Ltd. (STRS IT) climbed to the highest since Jan. 2, advancing 0.8 percent to 46.97 shekels. The food, snack and coffee maker said its coffee unit signed a five-year agreement with a German manufacturer to produce coffee.

Teva Pharmaceutical Industries Ltd. (TEVA IT), the generic drugmaker whose bestselling medicine is Copaxone, an injectable treatment for multiple sclerosis, advanced to the highest since May 31, increasing 0.9 percent to 173.50 shekels. U.S. and European regulators said they were reviewing Novartis AG ’s multiple sclerosis pill Gilenya after reports of 11 deaths.

Tower Semiconductor Ltd. (TSEM IT) rose 4.7 percent to 2.689 shekels, or the equivalent of 71 cents, the highest since Nov. 16. The U.S.-traded shares of the maker of customized chips rose 5.1 percent to 72 cents on Jan. 20.

--Editors: Susan Lerner, Daliah Merzaban

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net


The Good Business Issue
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus